September 24th 2024
Farberg discusses data recently published in Geriatrics demonstrating low rates of recurrence.
Skin Cancer and the Cutaneous Microbiome: Thinking Small May Produce Big Results
April 13th 2022The human microbiota and its involvement in human health and disease has been emphasized in recent years. Now, researchers have begun to explore whether a patient’s unique microbiota may influence skin cancer risk and response to therapy.
The Science Behind Using Circulating Tumor DNA for MCC
March 31st 2022In this second part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, explains the data behind the clinical trials on using circulating tumor DNA for merkel cell carcinoma (MCC). She expands on her talk from the 2022 American Academy of Dermatology Annual Meeting.
The Utility of Circulating Tumor DNA for Detecting Clinically Evident and Occult MCC
March 30th 2022In this first part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, explains the science behind her presentation on "The Utility of Circulating Tumor DNA for Detecting Clinically Evident and Occult Merkel Cell Carcinoma." This was presented at the 2022 American Academy of Dermatology Annual Meeting.